Literature DB >> 19618629

Vaccination as a tool to combat introductions of notifiable avian influenza viruses in Europe, 2000 to 2006.

I Capua1, A Schmitz, V Jestin, G Koch, S Marangon.   

Abstract

In late 2000, Italy was the first country of the European Union (EU) to implement an emergency vaccination programme against notifiable avian influenza. Vaccination with a conventional vaccine containing a seed strain with a different neuraminidase subtype from that of the field virus was used to complement biosecurity and restriction measures as part of an overall eradication strategy. This vaccination technique, in line with the Differentiating Infected from Vaccinated Animals system (DIVA), was applied several times until March 2008. This strategy enabled the identification of field exposed flocks and ultimately the eradication of low pathogenic H7N1, H7N3 and H5N2 infections. Italy was also the first country to implement a bivalent H5/H7 prophylactic vaccination programme of defined poultry populations, which was discontinued in December 2006. Following the incursion of highly pathogenic H5N1 into Europe, in 2005 and 2006, two other EU Member States, namely France and the Netherlands, implemented preventive vaccination programmes in 2006 but they targeted selected poultry populations different from those targeted in Italy and were implemented for short periods of time. Data generated during six years of experience with vaccination against avian influenza in Italy indicate that it is a useful tool to limit secondary spread and possibly prevent the introduction of low pathogenic avian influenza viruses in a susceptible population. The experience of France and the Netherlands provides data on vaccination of ducks and hobby poultry respectively and monitoring programmes associated with vaccination and difficulties related to their application. The advantages and disadvantages of vaccination need to be considered in the decision-making process, including the financial aspects of vaccination.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19618629     DOI: 10.20506/rst.28.1.1861

Source DB:  PubMed          Journal:  Rev Sci Tech        ISSN: 0253-1933            Impact factor:   1.181


  11 in total

1.  Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.

Authors:  David E Swayne; David L Suarez; Erica Spackman; Samadhan Jadhao; Gwenaelle Dauphin; Mia Kim-Torchetti; James McGrane; John Weaver; Peter Daniels; Frank Wong; Paul Selleck; Agus Wiyono; Risa Indriani; Yuni Yupiana; Elly Sawitri Siregar; Teguh Prajitno; Derek Smith; Ron Fouchier
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

2.  Characterization of a serologic marker candidate for development of a live-attenuated DIVA vaccine against porcine reproductive and respiratory syndrome virus.

Authors:  Hiep L X Vu; Byungjoon Kwon; Marcelo de Lima; Asit K Pattnaik; Fernando A Osorio
Journal:  Vaccine       Date:  2013-07-23       Impact factor: 3.641

Review 3.  Intervention strategies to reduce the risk of zoonotic infection with avian influenza viruses: scientific basis, challenges and knowledge gaps.

Authors:  Leslie D Sims
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

4.  Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpesvirus of turkeys as vector.

Authors:  Munir Iqbal
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

5.  Determinants of bluetongue virus virulence in murine models of disease.

Authors:  Marco Caporale; Rachael Wash; Attilio Pini; Giovanni Savini; Paola Franchi; Matthew Golder; Janet Patterson-Kane; Peter Mertens; Luigina Di Gialleonardo; Gisella Armillotta; Rossella Lelli; Paul Kellam; Massimo Palmarini
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

6.  H5-based DNA constructs derived from selected highly pathogenic H5N1 avian influenza virus induce high levels of humoral antibodies in Muscovy ducks against low pathogenic viruses.

Authors:  Olivier Guionie; Eric Niqueux; Michel Amelot; Stéphanie Bougeard; Véronique Jestin
Journal:  Virol J       Date:  2014-04-24       Impact factor: 4.099

7.  Avian influenza vaccination in Egypt: Limitations of the current strategy.

Authors:  Marisa Peyre; Hamid Samaha; Yilma Jobre Makonnen; Ahmed Saad; Amira Abd-Elnabi; Saber Galal; Toni Ettel; Gwenaelle Dauphin; Juan Lubroth; François Roger; Joseph Domenech
Journal:  J Mol Genet Med       Date:  2009-12-09

8.  Vaccination with recombinant RNA replicon particles protects chickens from H5N1 highly pathogenic avian influenza virus.

Authors:  Stefan J Halbherr; Terza Brostoff; Merve Tippenhauer; Samira Locher; Marianne Berger Rentsch; Gert Zimmer
Journal:  PLoS One       Date:  2013-06-10       Impact factor: 3.240

9.  Avirulent Marek's disease virus type 1 strain 814 vectored vaccine expressing avian influenza (AI) virus H5 haemagglutinin induced better protection than turkey herpesvirus vectored AI vaccine.

Authors:  Hongyu Cui; Hongbo Gao; Xianlan Cui; Yan Zhao; Xingming Shi; Qiaoling Li; Shuai Yan; Ming Gao; Mei Wang; Changjun Liu; Yunfeng Wang
Journal:  PLoS One       Date:  2013-01-03       Impact factor: 3.240

Review 10.  Prevalence and control of H7 avian influenza viruses in birds and humans.

Authors:  E M Abdelwhab; J Veits; T C Mettenleiter
Journal:  Epidemiol Infect       Date:  2014-01-15       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.